Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
134.00
-2.00 (-1.47%)
Jul 29, 2026, 1:30 PM CST

TPEX:3218 Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,1714,2044,2284,0823,4942,632
Revenue Growth
-2.56%-0.57%3.58%16.83%32.76%28.18%
Gross Profit
2,4412,4832,5332,4482,1401,636
Operating Income
1,3211,3801,3981,3121,081768.54
Net Income
960.761,0431,0651,045850.53595.43
Earnings Per Share
11.2912.2612.5312.3110.027.02
EPS Growth
-14.58%-2.15%1.79%22.85%42.76%23.22%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Medical Operations Department
3,2173,2593,4413,4722,7512,248
Optical Operation Department
1,1071,093995.97880.79742.82619
Adjustment and Elimination
-152.97-147.8-208.48-270.87--235.27
Total
4,1714,2044,2284,0823,4942,632

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,4052,1031,9171,6411,2801,040
Total Debt
1,1291,0631,054778.26783.65767.53
Net Cash (Debt)
1,2771,040863.2862.65495.99272.47
Net Cash Growth
-8.36%20.47%0.07%73.92%82.03%-41.23%
Net Cash Per Share
15.0112.2310.1610.165.853.21

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,6211,6661,6721,5541,268911.77
Capital Expenditures
-537.92-562.66-434.65-472.53-489.7-324.44
Free Cash Flow
1,0831,1041,2371,081778.47587.33
Free Cash Flow Growth
-18.47%-10.80%14.46%38.87%32.55%10.41%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
58.54%59.05%59.91%59.98%61.24%62.18%
Operating Margin
31.68%32.83%33.06%32.14%30.94%29.20%
Pretax Margin
29.96%32.01%31.17%32.30%31.26%29.00%
Profit Margin
23.04%24.80%25.18%25.60%24.34%22.62%
FCF Margin
25.98%26.25%29.27%26.48%22.28%22.32%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
7.7507.7507.5007.0005.6604.492
Dividend Per Share Growth
3.33%3.33%7.14%23.67%26.00%19.05%
Dividend Yield
5.70%5.62%4.11%2.84%2.30%2.06%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
11.8711.8615.9222.4628.0536.18
Forward PE
9.8110.6615.2419.4124.6727.75
P/FCF Ratio
10.4811.2113.6921.7130.6536.68
PS Ratio
2.722.944.015.756.838.19